PFE
PFIZER INC
NYSE · Healthcare · Drug Manufacturers - General · US
$27.60
−0.14%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- $0.79
- Revenue estimate
- $15.9B
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- $0.77
- EPS estimate
- $0.68
- Revenue actual
- $15.0B
- Revenue estimate
- $14.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 12
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +17.7%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $29
- PT range
- $26 – $31
- Analysts
- 7
3 Buy4 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | $0.68 | $0.77 | Beat 12.90% | $15.0B |
| May 5, 2026 | $0.72 | $0.75 | Beat 3.88% | $14.5B |
| Feb 3, 2026 | $0.57 | $0.66 | Beat 16.40% | $17.6B |
| Nov 4, 2025 | $0.63 | $0.87 | Beat 37.44% | $16.7B |
| Apr 29, 2025 | $0.67 | $0.92 | Beat 38.14% | $13.7B |
| Feb 4, 2025 | $0.47 | $0.63 | Beat 33.59% | $17.8B |
| May 1, 2024 | $0.52 | $0.82 | Beat 58.91% | $14.9B |
| Jan 30, 2024 | -$0.19 | $0.10 | Beat 152.63% | $14.2B |
| Oct 31, 2023 | -$0.32 | -$0.17 | Beat 46.88% | $13.2B |
| Aug 1, 2023 | $0.56 | $0.67 | Beat 19.64% | $12.7B |
| May 2, 2023 | $1.01 | $1.23 | Beat 21.66% | $18.3B |
| Jan 31, 2023 | $1.07 | $1.14 | Beat 6.84% | $24.3B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026